Max Smock
Stock Analyst at William Blair
(1.70)
# 3,408
Out of 5,146 analysts
18
Total ratings
54.55%
Success rate
-3.31%
Average return
Main Sectors:
Stocks Rated by Max Smock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SHC Sotera Health Company | Initiates: Outperform | n/a | $16.16 | - | 1 | Dec 18, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Outperform | n/a | $7.33 | - | 1 | May 21, 2025 | |
| MEDP Medpace Holdings | Downgrades: Market Perform | n/a | $438.08 | - | 4 | Apr 22, 2025 | |
| FTRE Fortrea Holdings | Reiterates: Market Perform | n/a | $10.34 | - | 5 | Mar 4, 2025 | |
| CRL Charles River Laboratories International | Downgrades: Market Perform | n/a | $167.56 | - | 2 | Jan 22, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | n/a | $101.00 | - | 1 | Jan 14, 2025 | |
| SLP Simulations Plus | Reiterates: Outperform | n/a | $11.81 | - | 4 | Nov 6, 2024 |
Sotera Health Company
Dec 18, 2025
Initiates: Outperform
Price Target: n/a
Current: $16.16
Upside: -
Lifecore Biomedical
May 21, 2025
Initiates: Outperform
Price Target: n/a
Current: $7.33
Upside: -
Medpace Holdings
Apr 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $438.08
Upside: -
Fortrea Holdings
Mar 4, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $10.34
Upside: -
Charles River Laboratories International
Jan 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $167.56
Upside: -
ICON Public Limited Company
Jan 14, 2025
Reiterates: Outperform
Price Target: n/a
Current: $101.00
Upside: -
Simulations Plus
Nov 6, 2024
Reiterates: Outperform
Price Target: n/a
Current: $11.81
Upside: -